Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (3s)-3-(4-((4-((morpholin-4-yl)methyl)phenyl)methoxy)-1-oxo-1,3-dihydro-2h-isoindol-2-yl)piperidine-2,6-dione
2. Cc-220
3. Cc-220 Hydrochloride
4. Cc220
5. Iberdomide Hydrochloride
1. 1323403-33-3
2. Cc-220
3. (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
4. Iberdomide [usan]
5. Cc220
6. 8v66f27x44
7. (3s)-3-[4-({4-[(morpholin-4-yl)methyl]phenyl}methoxy)-1-oxo-1,3-dihydro-2h-isoindol-2-yl]piperidine-2,6-dione
8. (3s)-3-[7-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3-oxo-1h-isoindol-2-yl]piperidine-2,6-dione
9. 2,6-piperidinedione, 3-(1,3-dihydro-4-((4-(4-morpholinylmethyl)phenyl)methoxy)-1-oxo-2h-isoindol-2-yl)-, (3s)-
10. (3s)-3-(4-((4-((morpholin-4-yl)methyl)phenyl)methoxy)-1-oxo-1,3-dihydro-2h-isoindol-2-yl)piperidine-2,6-dione
11. 8w7
12. Iberdomide(cc220)
13. Iberdomide [inn]
14. Iberdomide (usan/inn)
15. Iberdomide [who-dd]
16. Cc-220 (compound 6)
17. Iberdomide(cc-220)
18. Gtpl9618
19. Schembl2252414
20. Cc 220;cc-220;iberdomide
21. Chembl3989927
22. Unii-8v66f27x44
23. Bdbm65497
24. Bcp20299
25. Ex-a1425
26. Nsc833899
27. S8760
28. Zinc118417658
29. Compound 6 [pmid: 28425720]
30. Cs-6511
31. Db12101
32. Nsc-833899
33. (s)-3-[4-(4-morpholin-4-yl-methyl-benzyloxy)-1-oxo-1,3-dihydro-isoindol-2-yl]-piperidine-2,6-dione
34. Ac-32713
35. Hy-101291
36. C72310
37. D11134
38. A903376
39. Q27271066
40. Cc220;(s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione;cc-220
Molecular Weight | 449.5 g/mol |
---|---|
Molecular Formula | C25H27N3O5 |
XLogP3 | 1.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 449.19507097 g/mol |
Monoisotopic Mass | 449.19507097 g/mol |
Topological Polar Surface Area | 88.2 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 732 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of mature B-cell neoplasms
ABOUT THIS PAGE
25
PharmaCompass offers a list of Iberdomide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Iberdomide manufacturer or Iberdomide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Iberdomide manufacturer or Iberdomide supplier.
PharmaCompass also assists you with knowing the Iberdomide API Price utilized in the formulation of products. Iberdomide API Price is not always fixed or binding as the Iberdomide Price is obtained through a variety of data sources. The Iberdomide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Iberdomide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iberdomide, including repackagers and relabelers. The FDA regulates Iberdomide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iberdomide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Iberdomide supplier is an individual or a company that provides Iberdomide active pharmaceutical ingredient (API) or Iberdomide finished formulations upon request. The Iberdomide suppliers may include Iberdomide API manufacturers, exporters, distributors and traders.
Iberdomide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Iberdomide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Iberdomide GMP manufacturer or Iberdomide GMP API supplier for your needs.
A Iberdomide CoA (Certificate of Analysis) is a formal document that attests to Iberdomide's compliance with Iberdomide specifications and serves as a tool for batch-level quality control.
Iberdomide CoA mostly includes findings from lab analyses of a specific batch. For each Iberdomide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Iberdomide may be tested according to a variety of international standards, such as European Pharmacopoeia (Iberdomide EP), Iberdomide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Iberdomide USP).